AXGN
NASDAQ
$39.48
Axogen Inc (AXGN)
AxoGen, Inc., develops and markets surgical solutions for physical damage or transection of peripheral nerves. The company is headquartered in Alachua, Florida.
Sector:
Healthcare
Industry:
Medical Devices
Strong Buy
Target: $50.78 (+28.62%)
Market Cap
$2.06B
Free Cash Flow Yield
0.45%
Beta (5Y)
0.89
Price Chart
Valuation
Market Cap$2.06B
Forward P/E344.83
P/S8.66
P/B8.58
Profitability
Total Revenue (TTM)$238M
Gross Profit (TTM)$179M
EBITDA-$2.48M
Profit Margin-31.9%
Operating Margin-4.6%
EPS-$0.62
Financial Health
Free Cash Flow Yield0.45%
Growth & Risk
EPS 5Y CAGR+2.38%
Revenue 5Y CAGR+14.87%
Beta (5Y)0.89
Sharpe Ratio2.43